Nasdaq tops profit estimates on high-profile listings, robust data revenue

Nasdaq reported Q2 net revenue of $1.5B, up 15%, driven by a 19% jump in its capital access platforms segment to $621M. Adjusted EPS rose to $1.07 vs. $0.98 expected, helped by strong cash equities and equity options volumes with market services net revenue up 11% to $340M. While perps-related regulatory concerns have pressured sentiment toward exchanges (Nasdaq shares down >6% YTD), recurring revenue from its financial technology/software offerings is proving a cushion.

Analysis

The market is still pricing exchanges too much like cyclical toll roads and not enough like data/software platforms. NDAQ is the cleaner story because the incremental mix shift toward recurring products supports a higher multiple than a pure volume beat; the quarter matters less for the headline print than for proving that exchange franchises can compound even when cash equity activity normalizes.

The main loser from this setup is ICE, not because of near-term earnings damage, but because any narrative around crypto "perps" can compress its multiple faster than it hits cash flow. The second-order risk is investor generalization: if crypto-native leverage products are assumed to be structurally displacing regulated venues, every exchange gets discounted, even though the real substitution risk is mostly at the margin of retail crypto activity rather than institutional hedging and listed options.

Contrarian view: the consensus may be overestimating how durable the current volatility windfall is, while underestimating how sticky exchange monetization becomes when data, software, and surveillance products are bundled into client workflows. The key reversal catalyst over the next 1-3 months is a rapid drop in volatility and IPO cadence; that would expose who was just riding trading volumes versus who has true recurring revenue. Over 6-18 months, the key watch item is whether regulated crypto derivatives actually lose share to perps in a measurable way, not just in headlines.

Key Decisions for Investors

• Long NDAQ / short ICE for a 3-6 month relative-value trade. Thesis: NDAQ’s recurring data/software mix deserves a premium while ICE is more vulnerable to multiple compression from the crypto perps narrative. Target 10-15% relative alpha; invalidate if ICE re-accelerates data growth or NDAQ guides down its software attach rate.
• Tactically buy CME on volatility pullbacks for the next 1-2 months as a hedge against continued macro/geopolitical swings. The risk/reward is better on dips than after earnings strength; cut if VIX settles below 15 and market volumes normalize.
• Avoid chasing a broad long across the exchange group after the earnings pop. The beat is real, but the forward increment is likely valuation-driven; use strength to trim if NDAQ or CME rerate on multiple expansion without a follow-through in recurring revenue.